Skip to content

Research and Clinical Application of Intelligent Diagnosis for Neonatal Cranial Diseases Based on Multimodal Cranial Ultrasound Imaging

Research and Clinical Application of Intelligent Diagnosis for Neonatal Cranial Diseases Based on Multimodal Cranial Ultrasound Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129321
Enrollment
Unknown
Registered
2026-08-03
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Craniocerebral Diseases

Interventions

Gold Standard: Two senior physicians with at least 5 years of experience in neonatal cranial ultrasound diagnosis, who are blinded to the study groups and do not communicate with each other, will inde
Index test:artificial intelligence (AI) software-assisted cranial ultrasound

Sponsors

The Third Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Retrospective Study Phase (1) Neonates who underwent cranial ultrasound examination during hospitalization or outpatient visits in the Department of Neonatology or the Department of Obstetrics of our hospital from January 1, 2017 to July 1, 2026; (2) Complete and clear cranial ultrasound imaging data stored in the hospital PACS system, including standard section images such as coronal, sagittal, and axial planes; (3) Complete basic demographic information, perinatal data, clinical diagnoses, laboratory test results, ultrasound diagnoses, and follow-up outcome data recorded in the electronic medical record system; (4) Complete clinical data with no critical information missing, sufficient for AI model training and data analysis. 2. Prospective Study Phase (1) Approved by the hospital ethics committee, neonates who undergo routine neonatal cranial ultrasound examination in our hospital from August 1, 2026 to July 31, 2031; (2) No restrictions on gestational age, birth weight, or sex, covering full-term, preterm, high-risk, and other neonatal populations; (3) Guardians are informed of the study contents and provide informed consent in accordance with the ethics committee’s requirements; (4) Complete standard cranial ultrasound examination with clear imaging data, and able to cooperate with clinical follow-up.

Exclusion criteria

Exclusion criteria: (1) Cranial ultrasound images are blurred, defective, or missing standard planes, rendering them unsuitable for image analysis and annotation; (2) Critical clinical data—including perinatal information, clinical diagnosis, laboratory tests, and follow-up data—are missing, preventing complete data integration; (3) Presence of severe chromosomal abnormalities, congenital brain malformations, inherited metabolic diseases, or severe malformations of vital organs (e.g., heart, liver, kidneys) that may interfere with the independent diagnosis of intracranial lesions and interpretation of results; (4) The case records contain logical inconsistencies, duplicate entries, or other issues that compromise data authenticity; (5) In the prospective study, guardians refuse to cooperate, are lost to follow-up, or do not meet the relevant ethical requirements.

Design outcomes

Primary

MeasureTime frame
diagnostic accuracy;sensitivity (true positive rate);specificity (true negative rate);area under the ROC curve (AUC) of the AI model;misdiagnosis rate;inter?physician diagnostic agreement (Kappa value);

Secondary

MeasureTime frame
time per single diagnosis;missed diagnosis rate;

Countries

China

Contacts

Public ContactYi Wang

The Third Affiliated Hospital of Guangzhou Medical University

315489603@qq.com+86 134 1629 3807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026